The self-selection study will be introduced and discussed with the audience. A link to the current 2013 FDA guidance will be provided and discussion will touch on ongoing regulatory changes for non-prescription drug, dietary supplement and new dietary ingredient research. Even if you are not running a clinical trial on these topics today, this era of personalized medicine will touch many of our patients and the speaker wants to know how these regulatory changes affect your work.

Entire session info: https://2023.acrpnet.org/2023-program/2023/5/1/rapid-fire-session